1. Home
  2. OSRHW vs TGTX Comparison

OSRHW vs TGTX Comparison

Compare OSRHW & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSRHW
  • TGTX
  • Stock Information
  • Founded
  • OSRHW N/A
  • TGTX 1993
  • Country
  • OSRHW United States
  • TGTX United States
  • Employees
  • OSRHW 21
  • TGTX N/A
  • Industry
  • OSRHW
  • TGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSRHW
  • TGTX Health Care
  • Exchange
  • OSRHW Nasdaq
  • TGTX Nasdaq
  • Market Cap
  • OSRHW N/A
  • TGTX N/A
  • IPO Year
  • OSRHW 2023
  • TGTX 1995
  • Fundamental
  • Price
  • OSRHW $0.06
  • TGTX $36.56
  • Analyst Decision
  • OSRHW
  • TGTX Strong Buy
  • Analyst Count
  • OSRHW 0
  • TGTX 5
  • Target Price
  • OSRHW N/A
  • TGTX $40.80
  • AVG Volume (30 Days)
  • OSRHW N/A
  • TGTX 1.7M
  • Earning Date
  • OSRHW N/A
  • TGTX 08-05-2025
  • Dividend Yield
  • OSRHW N/A
  • TGTX N/A
  • EPS Growth
  • OSRHW N/A
  • TGTX N/A
  • EPS
  • OSRHW N/A
  • TGTX 0.24
  • Revenue
  • OSRHW N/A
  • TGTX $386,386,000.00
  • Revenue This Year
  • OSRHW N/A
  • TGTX $84.81
  • Revenue Next Year
  • OSRHW N/A
  • TGTX $38.34
  • P/E Ratio
  • OSRHW N/A
  • TGTX $150.21
  • Revenue Growth
  • OSRHW N/A
  • TGTX 33.54
  • 52 Week Low
  • OSRHW N/A
  • TGTX $16.65
  • 52 Week High
  • OSRHW N/A
  • TGTX $46.48
  • Technical
  • Relative Strength Index (RSI)
  • OSRHW N/A
  • TGTX 56.11
  • Support Level
  • OSRHW N/A
  • TGTX $35.18
  • Resistance Level
  • OSRHW N/A
  • TGTX $37.58
  • Average True Range (ATR)
  • OSRHW 0.00
  • TGTX 1.34
  • MACD
  • OSRHW 0.00
  • TGTX 0.08
  • Stochastic Oscillator
  • OSRHW 0.00
  • TGTX 56.32

About OSRHW OSR Holdings Inc. Warrant

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: